Corrigendum: Prevalence of Common Mental Disorders in South Asia: A Systematic Review and Meta-Regression Analysis.

[This corrects the article DOI: 10.3389/fpsyt.2020.573150.].

In the original article, there was a mistake in Table 1 “Pooled prevalence of mental disorders in South Asia” as published. Prevalence estimates of five of the psychiatric disorders were wrongly formatted with misplaced decimal points. The corrected Table 1 “Pooled prevalence of mental disorders in South Asia” appears below.

Table 1

Pooled prevalence of mental disorders in South Asia.

Outcome	Pooled prevalence (95% CI)	Data points	Sample size	I2	Q	P
Any disorder*	14.2% (12.9% to 15.7%)	394	8,63,657	99.67%	100099.20	<0.001
Depression	26.4% (23.6% to 29.4%)	135	173449	99.53%	28447	<0.001
Alcohol abuse	12.9% (8.8%−18.6%)	43	107893	99.79%	20683	<0.001
Anxiety	25.8% (19.4% to 33.5%)	36	70058	99.57%	8038.08	<0.001
Tobacco smoking	18.6% (14.3% to 24.0%)	34	84965	99.58%	7934.68	<0.001
PTSD	17.2% (11.0% to 25.9%)	21	42298	99.55%	4457.19	<0.001
Mixed anxiety and depression	28.4% (13.9% to 49.3%)	13	11102	99.41%	2043.01	<0.001
Suicidal behaviors	6.4% (3.1% to 12.4%)	13	25043	99.41%	2041	<0.001
Opiates	0.8% (0.2% to 2.5%)	12	37304	99.06%	1175.12	<0.001
Tobacco chewing	21.0% (14.0% to 30.3%)	10	10586	98.49%	852.95	<0.001
Cannabis	3.4% (1.5% to 7.3%)	9	10977	97.48%	317.52	<0.001
GAD	2.9% (0.3% to 26.5%)	5	31682	99.77%	1698.73	<0.001
Bipolar disorder	0.6% (0.3% to 1.0%)	4	7197	78.21%	13.77	0.003
IV Drug abuse	2.5% (0.1% to 32.1%)	4	15049	99.72%	1062.44	<0.001
Panic disorder	1.3% (0.5% to 3.4%)	4	28087	95.43%	65.67	<0.001
Stimulants	0.9% (0.5% to 1.6%)	4	1414	0%	1.09	0.78
OCD	1.6% (0.4% to 5.5%)	3	8784	96.57%	58.29	<0.001
Phobias	1.8% (0.4 % to 7.1%)	3	27754	98.16%	108.88	<0.001

Pooled estimate after adjusting for publication bias= 11.31% (10.05% to 12.69%).

In the original article, there was a mistake in Table 3 “Subgroup analyses presenting several factors associated with the prevalence of CMDs in included studies” as published. Prevalence estimates for subgroups of sampling methods were wrongly formatted. The corrected Table 3 “Subgroup analyses presenting several factors associated with the prevalence of CMDs in included studies” appears below.

Table 3

“Subgroup analyses presenting several factors associated with the prevalence of CMDs in included studies”.

Group	Pooled prevalence	Lower limit	Upper limit	Q-value	df (Q)	P-value
Method for identification of CMD
Diagnostic	5.22%	4.27%	6.37%	139.23	1.00	<0.001
Questionnaire	19.14%	17.38%	21.02%
Study setting
Community	13.05%	11.74%	14.49%	31.71	3.00	<0.001
Healthcare setting	29.01%	21.25%	38.24%
Other	26.53%	17.38%	38.26%
Refugee Settings	7.19%	3.19%	15.40%
Sampling Method
Non-random	19.0%	16.4%	21.9%	26.18	1.00	<0.001
Random	11.4%	10%	12.9%
Study design
Cross-sectional	13.93%	12.61%	15.35%	7.62	1.00	0.01
Longitudinal	30.52%	17.91%	46.94%
Background of participants
Mixed	14.37%	12.04%	17.06%	56.40	5.00	<0.001
National	18.18%	12.58%	25.53%
Provincial	1.91%	1.03%	3.51%
Rural	14.12%	10.96%	18.00%
Semi-urban	36.58%	13.84%	67.43%
Urban	17.47%	15.05%	20.18%

In the original article, there was an error. Prevalence estimates for panic disorder was wrongly formatted with misplaced decimal points in the results section of abstract and main text.

A correction has been made to the , :

We assessed the pooled prevalence for 17 different mental disorders over a period of 10 years. All the outcomes presented significant heterogeneity ranging from 0% to 99.79% for stimulant use and alcohol abuse, respectively. The prevalence of depressive symptoms was reported in 135 studies (I2 = 99.53%) yielding a prevalence of 26.4% among 173,449 participants. Alcohol abuse was reported in 43 studies yielding a prevalence of 12.9% (8.8%−18.6%, I2 = 99.79%, n = 107893); anxiety 25.8% (19.4% to 33.5%, I2 = 99.57%, n = 70,058); tobacco smoking 18.6% (14.3% to 24%, I2 = 99.58%, n = 84965); PTSD 17.2% (11% to 25.9%, I2 = 99.55%, n = 42298); mixed anxiety and depression 28.4% (13.9% to 49.3%, I2 = 99.41%, n = 11102); suicidal behaviors 6.4% (3.1% to 12.4%, I2 = 99.41%, n = 25043); misuse of opiates 0.8% (0.2% to 2.5%, I2 = 99.06%, n = 37304); tobacco chewing 21.0% (14.0% to 30.3%, I2 = 98.49%, n = 10586); use of cannabis 3.4% (1.5% to 7.3%, I2 = 97.48%, n = 10977); GAD 2.9% (0.3% to 26.5%, I2 = 99.57%, n = 70058); bipolar disorder 0.6% (0.3% to 1.0%, I2 = 78.21%, n = 7197); IV drug abuse 2.5% (0.1% to 32.1%, I2 = 99.72%, n = 15049); Panic disorder 1.3% (0.5% to 3.4%, I2 = 95.43%, n = 28087); stimulant use 0.9% (0.5% to 1.6%, I2 = 0%, n = 1414); OCD 1.6% (0.4% to 5.5%, I2 = 96.57%, n = 8784) and phobic disorders 1.8% (0.4% to 7.1%, I2 = 98.16%, n = 27754). Supplementary Figures 1–12 represent the forest plots for the above-mentioned disorders.

In the original article, there was an error. Prevalence estimates for panic disorder was wrongly formatted with misplaced decimal points in the results section of abstract and main text.

A correction has been made to the

A prevalence of depressive symptoms was 26.4% among 173,449 participants, alcohol abuse was 12.9% (n = 107,893); anxiety 25.8% (n = 70,058); tobacco smoking 18.6% (n = 84,965); PTSD 17.2% (n = 42,298); mixed anxiety and depression 28.4% (n = 11,102); suicidal behaviors 6.4% (n = 25,043); misuse of opiates 0.8% (n = 37,304); tobacco chewing 21.0% (n = 10,586); use of cannabis 3.4% (n = 10,977); GAD 2.9% (n = 70,058); bipolar disorder 0.6% (n = 7,197); IV drug abuse 2.5% (n = 15,049); panic disorder 1.3% (n = 28,087); stimulant use 0.9% (n = 1,414); OCD 1.6% (n = 8,784) and phobic disorders 1.8% (n = 27,754).

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.